Jump to content

Autoimmune disease

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by SolomonHume (talk | contribs) at 06:44, 5 September 2012. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Autoimmune disease
SpecialtyImmunology, rheumatology Edit this on Wikidata

Autoimmune diseases arise from an inappropriate immune response of the body against substances and tissues normally present in the body. In other words, the immune system mistakes some part of the body as a pathogen and attacks its own cells. This may be restricted to certain organs (e.g. in autoimmune thyroiditis) or involve a particular tissue in different places (e.g. Goodpasture's disease which may affect the basement membrane in both the lung and the kidney). The treatment of autoimmune diseases is typically with immunosuppression—medication which decreases the immune response. (For a detailed explanation of pathogenesis see Autoimmunity.)

Criteria

For a disease to be regarded as an autoimmune disease, it needs to answer to Witebsky's postulates (first formulated by Ernst Witebsky and colleagues in 1957 and modified in 1994):[1][2]

  • Direct evidence from transfer of pathogenic antibody or pathogenic T cells
  • Indirect evidence based on reproduction of the autoimmune disease in experimental animals
  • Circumstantial evidence from clinical clues

Classification

It is possible to classify autoimmune diseases by corresponding type of hypersensitivity: type II, type III, or type IV. (No type of autoimmune disease mimics type I hypersensitivity.)[3]

There is continuing debate about when a disease should be considered autoimmune, leading to different criteria such as Witebsky's postulates.

This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources.
Name: Accepted/
suspected 		Hypersensitivity

I, II, III, IV

Autoantibody Notes
Acute disseminated encephalomyelitis (ADEM) Accepted[4]
Addison's disease interferon omega; transglutaminase; aromatic acid carboxylase; GAD; HAI; 17 hydroxylase; 21 hydroxylase
Agammaglobulinemia IGHM; IGLL1: CD79A; CD79B; BLNK; LRRC8A
Alopecia areata Accepted[5][6] T-cells
Amyotrophic Lateral Sclerosis
Ankylosing Spondylitis Accepted[7][8][9] ANCA? CD8; HLA-B27
Antiphospholipid syndrome Accepted[4] anti-cardiolipin;anti pyruvate dehydrogenase; β2 glycoprotein I; phosphatidylserine; anti apoH; Annexin A5 HLA-DR7, HLA-B8, HLA-DR2, HLA-DR3
Antisynthetase syndrome
Atopic allergy I
Atopic dermatitis I
Autoimmune aplastic anemia
Autoimmune cardiomyopathy Accepted
Autoimmune enteropathy
Autoimmune hemolytic anemia Accepted II complement activation
Autoimmune hepatitis Accepted cell-mediated anti-mitochondrial antibodies; ANA; anti-smooth muscle antibodies, LKM-1; soluble liver antigen
Autoimmune inner ear disease Accepted [10]
Autoimmune lymphoproliferative syndrome Accepted TNFRSF6; defective Fas-CD95 apoptosis
Autoimmune peripheral neuropathy Accepted
Autoimmune pancreatitis Accepted ANA; anti-lactoferrin antibodiesanti-carbonic anhydrase antibodies; rheumatoid factor
Autoimmune polyendocrine syndrome Accepted Unknown or multiple APS-1 see Addison's disease
Autoimmune progesterone dermatitis Accepted
Autoimmune thrombocytopenic purpura Accepted anti gpIIb-IIIa or 1b-IX
Autoimmune urticaria Accepted [11]
Autoimmune uveitis Accepted HLAB-27?
Balo disease/Balo concentric sclerosis
Behçet's disease Accepted immune-mediated systemic vasculitis; linkage to HLA-B51 (HLA-B27); very different manifestations with ulcers as common symptom; also called Morbus Adamandiades-Behçet
Berger's disease IgA (elevated in 50% of patients), IgA (in mesangial deposits on kidney biopsy)
Bickerstaff's encephalitis Anti-GQ1b 2/3 patients similar to Guillain-Barré syndrome
Blau syndrome overlaps both sarcoidosis and granuloma annulare
Bullous pemphigoid IgG autoantibodies targeting the type XVII collagen component of hemidesmosomes [12]
Cancer
Castleman's disease Over expression of IL-6
Celiac disease Accepted[13][14][15] IV?? Anti-tissue transglutaminase antibodies anti-endomysial IgA, anti-gliadin IgA HLA-DQ8 and DQ2.5
Chagas disease Suspected[16]
Chronic inflammatory demyelinating polyneuropathy Anti-ganglioside antibodies:anti-GM1, anti-GD1a, anti-GQ1b similar to Guillain-Barré syndrome
Chronic recurrent multifocal osteomyelitis LPIN2, D18S60,similar to Majeed syndrome
Chronic obstructive pulmonary disease Suspected[17][18]
Churg-Strauss syndrome p-ANCA
Cicatricial pemphigoid anti-BP-1, anti BP-2 precipitates C3
Cogan syndrome
Cold agglutinin disease Accepted II IgM idiopathic or secondary to leukemia or infection
Complement component 2 deficiency
Contact dermatitis IV
Cranial arteritis aka Temporal arteritis; involves giant cells
CREST syndrome Anti-centromere antibodies Anti-nuclear antibodies
Crohn's disease (one of two types of idiopathic inflammatory bowel disease "IBD") Accepted[4] IV Innate immunity; Th17; Th1; ATG16L1; CARD15;XBP1;
Cushing's Syndrome cortisol binding globulin?
Cutaneous leukocytoclastic angiitis neutrophils
Dego's disease Vasculopathy
Dercum's disease Suspected Lipoid tissue.[19]
Dermatitis herpetiformis IgA; anti-epidermal transglutaminase antibodies
Dermatomyositis Accepted[20] histidine-tRNA anti-signal recognition peptide Anti-Mi-2 Anti-Jo1.[21] B- and T-cell perivascular inflammatory infiltrate on muscle biopsy
Diabetes mellitus type 1 Accepted[4] IV Glutamic acid decarboxylase antibodies (GADA), islet cell antibodies (ICA), and insulinoma-associated autoantibodies (IA-2), anti-insulin antibodies HLA-DR3, HLA-DR4
Diffuse cutaneous systemic sclerosis anti-nuclear antibodies, anti-centromere and anti-scl70/anti-topoisomerase antibodies[22] COL1A2 and TGF-β1
Dressler's syndrome myocardial neo-antigens formed as a result of the MI
Drug-induced lupus anti-histone
Discoid lupus erythematosus III IL-2 and IFN-gamma>[23]
Eczema LEKTI, SPINK5,[24] filaggrin.,[25] Brain-derived neurotrophic factor (BDNF) and Substance P.[26]
Endometriosis Suspected[27]
Enthesitis-related arthritis[28] . MMP3[29] TRLR2, TLR4,[30] ERAP1[31]
Eosinophilic fasciitis Accepted
Eosinophilic gastroenteritis IgE IL-3, IL-5, GM-CSF, eotaxin
Epidermolysis bullosa acquisita COL7A1
Erythema nodosum
Erythroblastosis fetalis II ABO, Rh, Kell antibodies mother's immune system attacks fetus
Essential mixed cryoglobulinemia
Evan's syndrome
Fibrodysplasia ossificans progressiva ACVR1 Lymphocytes express increased BMP4
Fibrosing alveolitis (or Idiopathic pulmonary fibrosis) SFTPA1, SFTPA2, TERT, and TERC.[32]
Gastritis serum antiparietal and anti-IF antibodies
Gastrointestinal pemphigoid Accepted
Giant cell arteritis macrophage giant cells
Glomerulonephritis Sometimes IgA see Buerger's disease for IgA; Membranous glomerulonephritis for IgG; Membranoproliferative/mesangiocapillary GN (Complement activation); Goodpasture's syndrome; Wegener's granulomatosis
Goodpasture's syndrome Accepted[4] II Anti-Basement Membrane Collagen Type IV Protein
Graves' disease Accepted[4] II thyroid autoantibodies (TSHR-Ab) that activate the TSH-receptor (TSHR)
Guillain-Barré syndrome (GBS) Accepted[4] IV Anti-ganglioside
Hashimoto's encephalopathy Accepted[4] IV alpha-enolase[33]
Hashimoto's thyroiditis Accepted[4] IV antibodies against thyroid peroxidase and/or thyroglobulin HLADR5, CTLA-4
Henoch-Schonlein purpura immunoglobulin A (IgA) and complement component 3 (C3)
Herpes gestationis aka Gestational Pemphigoid IgG and C3 misdirected antibodies intended to protect the placenta
Hidradenitis suppurativa Suspected[34]
Hughes-Stovin syndrome
Hypogammaglobulinemia IGHM, IGLL1, CD79A, BLNK, LRRC8A, CD79B
Idiopathic inflammatory demyelinating diseases a variant of multiple sclerosis
Idiopathic pulmonary fibrosis SFTPA1, SFTPA2, TERT, and TERC.[32]
Idiopathic thrombocytopenic purpura (See Autoimmune thrombocytopenic purpura) Accepted[4] II glycoproteins IIb-IIIa or Ib-IX, immunoglobulin G
IgA nephropathy III? IgA produced from marrow rather than MALT
Inclusion body myositis similar to polymyositis but does not respond to steroid therapy-activated T8 cells
Chronic inflammatory demyelinating polyneuropathy anti-ganglioside antibodies similar to Guillain–Barré syndrome
Interstitial cystitis Suspected[35] Mast cells
Juvenile idiopathic arthritis aka Juvenile rheumatoid arthritis inconsistent ANA Rheumatoid factor
Kawasaki's disease Suspected ITPKC HLA-B51
Lambert-Eaton myasthenic syndrome voltage-gated calcium channels; Q-type calcium channel, synaptogagmin, muscarinic acetylcholine receptor M1 HLA-DR3-B8
Leukocytoclastic vasculitis
Lichen planus
Lichen sclerosus
Linear IgA disease (LAD)
Lou Gehrig's disease (Also Amyotrophic lateral sclerosis) VCP, ATXN2, OPTN, FIG4, TARDBP, ANG, VAPB, FUS, SETX, ALS2, SOD1
Lupoid hepatitis aka Autoimmune hepatitis ANA and SMA,[36] LKM-1, LKM-2 or LKM-3; antibodies against soluble liver antigen[37][38](anti-SLA, anti-LP) no autoantibodies detected (~20%)[citation needed]
Lupus erythematosus Accepted[4] III Anti-nuclear antibodies[39] anti-Ro.[40] Also, they are often present in Sjögren's syndrome.[41][42]
Majeed syndrome LPIN2
Ménière's disease III? major peripheral myelin protein P0[43]
Microscopic polyangiitis p-ANCA myeloperoxidase binds to neutrophils causing them to degranulate and damages endothelium
Miller-Fisher syndrome see Guillain-Barre Syndrome Accepted anti-GQ1b
Mixed connective tissue disease Accepted[4] anti-nuclear antibody anti-U1-RNP HLA-DR4
Morphea Suspected[44]
Mucha-Habermann disease aka Pityriasis lichenoides et varioliformis acuta T-cells
Multiple sclerosis Suspected IV HLA-DR2, PECAM-1[45] Anti-Myelin Basic Protein
Myasthenia gravis Accepted[4] II nicotinic acetylcholine receptor MuSK protein HA-B8 HLA-DR3 HLA-DR1
Myositis see Dermatomyositis and Polymyositis see Inclusion-body-myositis
Narcolepsy[46][47] Suspected[48] II? hypocretin or orexin[49] HLA-DQB1*0602[50]
Neuromyelitis optica (also Devic's disease) II? NMO-IgG aquaporin 4.[51][52]
Neuromyotonia Suspected[53] II? voltage-gated potassium channels.[53]
Occular cicatricial pemphigoid II? BP-1, BP-2 C3 deposition
Opsoclonus myoclonus syndrome Suspected IV? Lymphocyte recruitment to CSF[54]
Ord's thyroiditis
Palindromic rheumatism anti-cyclic citrullinated peptide antibodies (anti-CCP) and antikeratin antibodies (AKA)[55]
PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcus) Suspected II? antibodies against streptococcal infection serve as auto-antibodies
Paraneoplastic cerebellar degeneration IV?[56] II? anti-Yo[57] (anti-cdr-2[58] in purkinje fibers) anti-Hu, anti-Tr, antiglutamate receptor
Paroxysmal nocturnal hemoglobinuria (PNH) Sometimes(?) complement attacks RBCs
Parry Romberg syndrome ANA
Parsonage-Turner syndrome
Pars planitis
Pemphigus vulgaris Accepted[4] II Anti-Desmoglein 3
Pernicious anaemia Accepted[59] II anti-parietal cell antibody
Perivenous encephalomyelitis
POEMS syndrome interleukin 1β, interleukin 6 and TNFα. vascular endothelial growth factor (VEGF), given the .[60]
Polyarteritis nodosa
Polymyalgia rheumatica
Polymyositis Accepted[20] IFN-gamma, IL-1, TNF-alpha
Primary biliary cirrhosis Accepted[61] Anti-p62, Anti-sp100, Anti-Mitochondrial(M2)Anti-Ro aka SSA.[40] Also, they are often present in Sjögren's syndrome.[41][42]
Primary sclerosing cholangitis HLA-DR52a overlap with primary biliary cirrhosis?
Progressive inflammatory neuropathy Suspected
Psoriasis Accepted[62] IV? CD-8 T-cells, HLA-Cw6, IL-12b, IL-23b, TNFalpha, NF-κB
Psoriatic arthritis Accepted[63] IV? HLA=B27
Pyoderma gangrenosum Can occur in conjunction with other immune-related disorders
Pure red cell aplasia
Rasmussen's encephalitis anti-NR2A antibodies
Raynaud phenomenon Suspected Can occur in conjunction with other immune-related disorders
Relapsing polychondritis Accepted[64]
Reiter's syndrome
Restless leg syndrome Suspected May occur in Sjögren's syndrome, celiac disease, and rheumatoid arthritis or in derangements of iron metabolism
Retroperitoneal fibrosis
Rheumatoid arthritis Accepted[4] III Rheumatoid factor (anti-IgGFc), Anti-MCV, ACPAs(Vimentin HLA-DR4, PTPN22, depleted B cells, TNF alpha, IL-17, (also maybe IL-1, 6, and 15)
Rheumatic fever II streptococcal M protein cross reacts with human myosin,[65] anti-DNase B, ASO
Sarcoidosis Suspected IV[66][67] BTNL2; HLA-B7-DR15; HLA DR3-DQ2.[68]
Schizophrenia Suspected[69][70][71]
Schmidt syndrome another form of APS anti-21 hydroxylase, anti-17 hydroxylase[72] DQ2, DQ8 and DRB1*0404
Schnitzler syndrome IgM?
Scleritis
Scleroderma Suspected[44] IV? Scl-70 Anti-topoisomerase dysregulated apoptosis?
Serum Sickness III
Sjögren's syndrome Accepted[4] Anti-ro.[40] Also, they are often present in Sjögren's syndrome.[41][42]
Spondyloarthropathy HLA-B27
Still's disease see Juvenile Rheumatoid Arthritis ANA macrophage migration inhibitory factor[73]
Stiff person syndrome Suspected glutamic acid decarboxylase (GAD),[74] GLRA1 (glycine receptor
Subacute bacterial endocarditis (SBE) III [75] essential mixed cryoglobulinemia
Susac's syndrome
Sweet's syndrome GCSF
Sydenham chorea see PANDAS
Sympathetic ophthalmia ocular antigens following trauma
Systemic lupus erythematosis see Lupus erythematosis III
Takayasu's arteritis
Temporal arteritis (also known as "giant cell arteritis") Accepted[4] IV
Thrombocytopenia II glycoproteins IIb-IIIa or Ib-IX in ITP anti-ADAMTS13 in TTP.[76] and HUS anti-cardiolipin (anti-cardiolipin antibodies) and β2 glycoprotein I in Antiphospholipid syndrome anti-HPA-1a, anti-HPA-5b, and others[77] in NAIT multiple mechanisms
Tolosa-Hunt syndrome
Transverse myelitis Accepted Transverse Myelitis is a rare neurological disorder that is part of a spectrum of neuroimmunologic diseases of the central nervous system. http://www.myelitis.org/
Ulcerative colitis (one of two types of idiopathic inflammatory bowel disease "IBD") Accepted[4] IV
Undifferentiated connective tissue disease different from Mixed connective tissue disease Accepted anti-nuclear antibody HLA-DR4
Undifferentiated spondyloarthropathy
Urticarial vasculitis II? anti C1q antibodies[78] clinically may resemble type I hypersensitivity!
Vasculitis Accepted[12] III sometimes ANCA
Vitiligo Suspected[79][80] NALP-1 RERE, PTPN22, LPP, IL2RA, GZMB, UBASH3A and C1QTNF6
Wegener's granulomatosis Accepted[81] Anti-neutrophil cytoplasmic(cANCA)

Development of therapies

In both autoimmune and inflammatory diseases the condition arises through aberrant reactions of the human adaptive or innate immune systems. In autoimmunity, the patient’s immune system is activated against the body's own proteins. In inflammatory diseases, it is the overreaction of the immune system, and its subsequent downstream signaling (TNF, IFN, etc.), which causes problems. Mitigation of inflammation by activation of anti-inflammatory genes and the suppression of inflammatory genes in immune cells is a promising way of novel therapies.[82][83][84]

A substantial minority of the population suffers from these diseases, which are often chronic, debilitating, and life-threatening. There are more than eighty illnesses caused by autoimmunity.[85] It has been estimated that autoimmune diseases are among the ten leading causes of death among women in all age groups up to 65 years.[86]

See also

Further reading

  • Vinay Kumar, Abul K. Abbas, Nelson Fausto, Jon Aster, Robbins and Cotran Pathologic Basis of Disease, Elsevier, 8th edition, 2010, 1464 pp., ISBN 978-1-4160-3121-5
  • Handbook of Systemic Autoimmune Diseases, edited by Ronald Asherson, Elsevier, in 10 Volumes [1] :
    • Ronald Asherson, Andrea Doria, Paolo Pauletto, The Heart in Systemic Autoimmune Diseases, Volume 1, 2004, ISBN 978-0-444-51398-4, ISBN 0-444-51398-1
    • Ronald Asherson, Andrea Doria, Paolo Pauletto, Pulmonary Involvement in Systemic Autoimmune Diseases, Volume 2, 2005, ISBN 978-0-444-51652-7, ISBN 0-444-51652-2
    • Ronald Asherson, Doruk Erkan, Steven Levine, The Neurologic Involvement in Systemic Autoimmune Diseases, Volume 3, 2005, ISBN 978-0-444-51651-0, ISBN 0-444-51651-4
    • Michael Lockshin, Ware Branch (eds), Reproductive and Hormonal Aspects of Systemic Autoimmune Diseases, Volume 4, 2006, ISBN 978-0-444-51801-9, ISBN 0-444-51801-0
    • Piercarlo Sarzi-Puttini, Ronald Asherson, Andrea Doria, Annegret Kuhn, Giampietro Girolomoni (eds), The Skin in Systemic Autoimmune Diseases, Volume Volume 5, 2006, ISBN 978-0-444-52158-3, ISBN 0-444-52158-5
    • Rolando Cimaz, Ronald Asherson, Thomas Lehman (eds), Pediatrics in Systemic Autoimmune Diseases, Volume 6, 2008, ISBN 978-0-444-52971-8, ISBN 0-444-52971-3
    • Justin Mason, Ronald Asherson, Charles Pusey (eds), The Kidney in Systemic Autoimmune Diseases, Volume 7, 2008, ISBN 978-0-444-52972-5, ISBN 0-444-52972-1
    • Ronald Asherson, Manel Ramos-Casals, Joan Rodes, Josep Font, Digestive Involvement in Systemic Autoimmune Diseases, Volume 8, 2008, ISBN 978-0-444-53168-1, ISBN 0-444-53168-8
    • Ronald Asherson, Sara Walker, Luis Jara, Endocrine Manifestations of Systemic Autoimmune Diseases, Volume 9, 2008, ISBN 978-0-444-53172-8, ISBN 0-444-53172-6
    • R. Cervera, Ronald Asherson, Munther Khamashta, Joan Carles Reverter (eds), Antiphospholipid Syndrome in Systemic Autoimmune Diseases, Volume 10, 2009, ISBN 978-0-444-53169-8, ISBN 0-444-53169-6

References

  1. ^ Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW (1957). "Chronic thyroiditis and autoimmunization". J. Am. Med. Assoc. 164 (13): 1439–47. doi:10.1001/jama.1957.02980130015004. PMID 13448890.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ Rose NR, Bona C (1993). "Defining criteria for autoimmune diseases (Witebsky's postulates revisited)". Immunol. Today. 14 (9): 426–30. doi:10.1016/0167-5699(93)90244-F. PMID 8216719. {{cite journal}}: Unknown parameter |month= ignored (help)
  3. ^ Parham, Peter (2005). The immune system. NY: Garland Science. p. 344. ISBN 0-8153-4093-1.
  4. ^ a b c d e f g h i j k l m n o p q r Autoimmune+Diseases at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
  5. ^ American Academy of Dermatology, http://www.aad.org/public/publications/pamphlets/common_alopecia.html
  6. ^ htmlThe University of Texas MD Anderson Cancer Center, http://www.mdanderson.org/patient-and-cancer-information/cancer-information/cancer-types/alopecia-areata/index.html
  7. ^ HLA-B27 and Ankylosing Spondylitis, http://www.hlab27.com
  8. ^ Inflammatory Diseases of Immune Dysregulation, http://www.idid.us
  9. ^ Khan MA, Khan MK (1982). "Diagnostic Value of HLA-B27 Testing in Ankylosing Spondylitis and Reiter's Syndrome". Annals of Internal Medicine. 96 (1): 70–76, author reply 76. PMID 7053711.
  10. ^ "Autoimmune Inner Ear Disease, Baylor College of Medicine". 1993.
  11. ^ Soundararajan S, Kikuchi Y, Kusumam J, Kaplan AP (2004). "Functional | assessment of pathogenic IgG subclass in chronic autoimmune urticaria". Journal of Allergy and Clinical. 115 (4): 815–21. doi:10.1016/j.jaci.2004.12.1120. {{cite journal}}: Unknown parameter |unused_data= ignored (help)CS1 maint: multiple names: authors list (link)
  12. ^ a b "Autoimmune Disorders: Immune Disorders: Merck Manual Home Health Handbook".
  13. ^ "Celiac Disease".
  14. ^ Meize-Grochowski R (2005). "Celiac disease: a multisystem autoimmune disorder". Gastroenterol Nurs. 28 (5): 394–402, quiz 403–4. doi:10.1097/00001610-200509000-00005. PMID 16234635.
  15. ^ Sollid LM, Jabri B (2005). "Is celiac disease an autoimmune disorder?". Curr. Opin. Immunol. 17 (6): 595–600. doi:10.1016/j.coi.2005.09.015. PMID 16214317. {{cite journal}}: Unknown parameter |month= ignored (help)
  16. ^ Hyland KV, Engman DM (2006). "Further thoughts on where we stand on the autoimmunity hypothesis of Chagas disease". Trends Parasitol. 22 (3): 101–2, author reply 103. doi:10.1016/j.pt.2006.01.001. PMID 16446117.
  17. ^ Agustí A, MacNee W, Donaldson K, Cosio M. (2003). "Hypothesis: does COPD have an autoimmune component?". Thorax. 58 (10): 832–834. doi:10.1136/thorax.58.10.832. PMC 1746486. PMID 14514931.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  18. ^ Lee SH, Goswami S, Grudo A; et al. (2007). "Antielastin autoimmunity in tobacco smoking-induced emphysema". Nat. Med. 13 (5): 567–9. doi:10.1038/nm1583. PMID 17450149. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  19. ^ Singal A, Janiga JJ, Bossenbroek NM, Lim HW (2007). "Dercum's disease (adiposis dolorosa): a report of improvement with infliximab and methotrexate". J Eur Acad Dermatol Venereol. 21 (5): 717. doi:10.1111/j.1468-3083.2006.02021.x. PMID 17448013. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  20. ^ a b "Polymyositis and Dermatomyositis: Autoimmune Disorders of Connective Tissue: Merck Manual Home Health Handbook".
  21. ^ Ghirardello, A (2006). "Clinical implications of autoantibody screening in patients with autoimmune myositis". Autoimmunity. 39 (3): 217–221. doi:10.1080/08916930600622645. PMID 16769655. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  22. ^ Jimenez SA, Derk CT (2004). "Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis". Ann. Intern. Med. 140 (1): 37–50. PMID 14706971.
  23. ^ Toro JR, Finlay D, Dou X, Zheng SC, LeBoit PE, Connoly KM. "Detection of Type 1 Cytokines in Discoid Lupus Erythematosus". Annals of Internal Medicine. 136: 1497–1501.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  24. ^ Walley AJ, Chavanas S, Moffatt MF; et al. (2001). "Gene polymorphism in Netherton and common atopic disease". Nat. Genet. 29 (2): 175–8. doi:10.1038/ng728. PMID 11544479. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  25. ^ Palmer CN; et al. (2006). "Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis". Nature Genetics. 38 (4): 441–6. doi:10.1038/ng1767. PMID 16550169. {{cite journal}}: Explicit use of et al. in: |author= (help)
  26. ^ "'Blood chemicals link' to eczema -- Scientists have identified two blood chemicals linked to itchy eczema, offering new treatment possibilities". BBC News. 26 August 2007. Retrieved 2007-10-16.
  27. ^ Gleicher N, el-Roeiy A, Confino E, Friberg J (1987). "Is endometriosis an autoimmune disease?". Obstetrics and gynecology. 70 (1): 115–22. PMID 3110710.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  28. ^ Colbert RA (2010). "Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond". Nat Rev Rheumatol. 6 (8): 477–85. doi:10.1038/nrrheum.2010.103.
  29. ^ Viswanath V, Myles A, Dayal R, Aggarwal A. "Levels of Serum Matrix Metalloproteinase-3 Correlate with Disease Activity in the Enthesitis-related Arthritis Category of Juvenile Idiopathic Arthritis". J Rheumatol.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  30. ^ Myles A, Aggarwal A (2011). "Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis". Rheumatology (Oxford). 50 (3): 481–8. doi:10.1093/rheumatology/keq362. PMID 21097451. {{cite journal}}: Unknown parameter |month= ignored (help)
  31. ^ Hinks A, Martin P, Flynn E, Eyre S, Packham J; Childhood Arthritis Prospective Study (CAPS); BSPAR study group, Barton A, Worthington J, Thomson W. (2001). "Subtype specific genetic associations for juvenile idiopathic arthritis: ERAP1 with the enthesitis related arthritis subtype and IL23R with juvenile psoriatic arthritis". Arthritis Res Ther. 13 (1): R12. doi:10.1186/ar3235. PMC 3241356. PMID 21281511.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  32. ^ a b Online Mendelian Inheritance in Man (OMIM): 178500
  33. ^ Yoneda M, Fujii A, Ito A, Yokoyama H, Nakagawa H, Kuriyama M (2007). "High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy". J. Neuroimmunol. 185 (1–2): 195–200. doi:10.1016/j.jneuroim.2007.01.018. PMID 17335908. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  34. ^ "Clinical Trial: Etanercept in Hidradenitis Suppurativa". Retrieved 2007-07-08.
  35. ^ Kárpáti F, Dénes L, Büttner K (1975). "[Interstitial cystitis=autoimmune cyatitis? Interstitial as a participating disease in lupus erythematosus]". Zeitschrift für Urologie und Nephrologie (in German). 68 (9): 633–9. PMID 1227191.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  36. ^ Bogdanos DP, Invernizzi P, Mackay IR, Vergani D (2008). "Autoimmune liver serology: Current diagnostic and clinical challenges". World J. Gastroenterol. 14 (21): 3374–3387. doi:10.3748/wjg.14.3374. PMC 2716592. PMID 18528935. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  37. ^ "autoimmune hepatitis".
  38. ^ "Medscape & eMedicine Log In".
  39. ^ Ehrenstein MR (1999). "Antinuclear antibodies and lupus: causes and consequences". Rheumatology (Oxford). 38 (8): 691–3. doi:10.1093/rheumatology/38.8.691. PMID 10501412. {{cite journal}}: Unknown parameter |month= ignored (help)
  40. ^ a b c Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15804706, please use {{cite journal}} with |pmid=15804706 instead.
  41. ^ a b c Franceschini F, Cavazzana I (2005). "Anti-Ro/SSA and La/SSB antibodies". Autoimmunity. 38 (1): 55–63. doi:10.1080/08916930400022954. PMID 15804706. {{cite journal}}: Unknown parameter |month= ignored (help)
  42. ^ a b c V Goëb; et al. (2007). "Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome". Clin. Exp. Immunol. 148 (2): 281–7. doi:10.1111/j.1365-2249.2007.03337.x. PMC 1868868. PMID 17286756. {{cite journal}}: Explicit use of et al. in: |author= (help)
  43. ^ Boulassel MR, Deggouj N, Tomasi JP, Gersdorff M. (2001 Jan). "Inner ear autoantibodies and their targets in patients with autoimmune inner ear diseases.| journa;=Acta Otolaryngol". 12 (1): 28–34. {{cite journal}}: Check date values in: |year= (help); Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link) CS1 maint: year (link)
  44. ^ a b Takehara K, Sato S (2005). "Localized scleroderma is an autoimmune disorder". Rheumatology (Oxford, England). 44 (3): 274–9. doi:10.1093/rheumatology/keh487. PMID 15561734.
  45. ^ Kalinowska A, Losy J. (2006). "PECAM-1, a key player in neuroinflammation". Eur J Neurol. 13 (12): 1284–90274. doi:10.1111/j.1468-1331.2006.01640.x. PMID 17116209.
  46. ^ Hallmayer J, Faraco J, Lin L; et al. (2009). "Narcolepsy is strongly associated with the TCR alpha locus". Nat. Genet. 41 (6): 708–11. doi:10.1038/ng.372. PMC 2803042. PMID 19412176. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  47. ^ "Narcolepsy is an autoimmune disorder, Stanford researcher says". EurekAlert. American Association for the Advancement of Science. 2009-05-03. Archived from the original on 10 May 2009. Retrieved 2009-05-31. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  48. ^ Carlander, B., Eliaou J.F., Billiard M. (1993). "Autoimmune hypothesis in narcolepsy". Neurophysiol. Clin. 23 (1): 15–22. doi:10.1016/S0987-7053(05)80279-5. PMID 8446070.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  49. ^ Mignot, E (2001). "A commentary on the neurobiology of the hypocretin/orexin system". Neuropsychopharmacology. 25 (5 Suppl): S5–13. doi:10.1016/S0893-133X(01)00316-5. PMID 11682267. {{cite journal}}: More than one of |pages= and |page= specified (help)
  50. ^ Maret, S (2005). "Genetics of narcolepsy and other major sleep disorders" (PDF). Swiss Medical Weekly. 135 (45–46). EMH Swiss Medical Publishers Ltd.: 662–5. PMID 16453205. Archived from the original (PDF) on 14 April 2008. Retrieved 2008-03-07. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |deadurl= ignored (|url-status= suggested) (help); Unknown parameter |month= ignored (help)
  51. ^ Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005). "IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel". J. Exp. Med. 202 (4): 473–477. doi:10.1084/jem.20050304. PMC 2212860. PMID 16087714.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  52. ^ Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA (2006). "Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression". Arch. Neurol. 63 (7): 964–968. doi:10.1001/archneur.63.7.964. PMID 16831965.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  53. ^ a b Maddison P (2006). "Neuromyotonia". Clinical Neurophysiology. 117 (10): 2118–27. doi:10.1016/j.clinph.2006.03.008. PMID 16843723.
  54. ^ Pranzatelli, M. R., Travelstead, A. L., Tate, E. D., Allison, T. J.,Moticka, E. J., Franz, D. N., Nigro, M. A., Parke, J. T., Stumpf, D. A., Verhulst, S. J. (2004). "B- and T-cell markers in opsoclonus-myoclonus syndrome: Immunophenotyping of CSF lymphocytes". Neurology. 62 (9): 1526–1532. doi:10.1212/WNL.62.9.1526. PMID 15136676. {{cite journal}}: Unknown parameter |vol= ignored (|volume= suggested) (help)CS1 maint: multiple names: authors list (link)
  55. ^ Powell A, Davis P, Jones N, Russell AS (2008). "Palindromic rheumatism is a common disease: comparison of new-onset palindromic rheumatism compared to new-onset rheumatoid arthritis in a 2-year cohort of patients". J. Rheumatol. 35 (6): 992–4. PMID 18412310. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  56. ^ Darnell,R.B. (1996), "Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain", Proc Natl Acad Sci U S A, 93 (10): 4529–4536, PMC 39311, PMID 8643438
  57. ^ Peterson,K., Rosenblum, J.K., Kotanides,H., Posner,J.B. (1992), "Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients", Neurology, 42 (10): 1931–1937, PMID 1407575{{citation}}: CS1 maint: multiple names: authors list (link)
  58. ^ Albert,M.L., Austin,L.M., Darnell,R.B. (2000), "Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration", Ann Neurol, 47 (1): 9–17, PMID 10632096{{citation}}: CS1 maint: multiple names: authors list (link)
  59. ^ "MedlinePlus Medical Encyclopedia: Pernicious anemia". Archived from the original on 9 May 2008. Retrieved 2008-04-05. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  60. ^ Dispenzieri A, Kyle RA, Lacy MQ; et al. (2003). "POEMS syndrome: definitions and long-term outcome". Blood. 101 (7): 2496–506. doi:10.1182/blood-2002-07-2299. PMID 12456500. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  61. ^ National Psoriasis Foundation, http://www.psoriasis.org/home/learn01.php
  62. ^ National Psoriasis Foundation, http://www.psoriasis.org/home/learn02.php
  63. ^ "Relapsing Polychondritis: Autoimmune Disorders of Connective Tissue: Merck Manual Home Health Handbook".
  64. ^ Faé KC, da Silva DD, Oshiro SE; et al. (2006). "Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease". J. Immunol. 176 (9): 5662–70. PMID 16622036. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  65. ^ "eMedicine - Hypersensitivity Reactions, Delayed : Article by Walter Duane Hinshaw". Archived from the original on 15 September 2008. Retrieved 2008-09-18. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  66. ^ Morell F, Levy G, Orriols R, Ferrer J, De Gracia J, Sampol G (2002). "Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis". Chest. 121 (4): 1239–44. doi:10.1378/chest.121.4.1239. PMID 11948059. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  67. ^ Grunewald J, Eklund A, Olerup O (2004). "Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients". Am. J. Respir. Crit. Care Med. 169 (6): 696–702. doi:10.1164/rccm.200303-459OC. PMID 14656748. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  68. ^ Eaton WW, Byrne M, Ewald H; et al. (2006). "Association of schizophrenia and autoimmune diseases: linkage of Danish national registers". The American Journal of Psychiatry. 163 (3): 521–8. doi:10.1176/appi.ajp.163.3.521. PMID 16513876. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  69. ^ Jones AL, Mowry BJ, Pender MP, Greer JM (2005). "Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?". Immunol. Cell Biol. 83 (1): 9–17. doi:10.1111/j.1440-1711.2005.01305.x. PMID 15661036.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  70. ^ Strous RD, Shoenfeld Y (2006). "Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited". J. Autoimmun. 27 (2): 71–80. doi:10.1016/j.jaut.2006.07.006. PMID 16997531.
  71. ^ de Carmo Silva R, Kater CE, Dib SA; et al. (2000). "Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III". Eur. J. Endocrinol. 142 (2): 187–94. doi:10.1530/eje.0.1420187. PMID 10664529. Retrieved 2008-07-25. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  72. ^ De Benedetti F, Meazza C, Vivarelli M; et al. (2003). "Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis". Arthritis Rheum. 48 (5): 1398–407. doi:10.1002/art.10882. PMID 12746913. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  73. ^ Murinson BB (2004). "Stiff-person syndrome". Neurologist. 10 (3): 131–7. doi:10.1097/01.nrl.0000126587.37087.1a. PMID 15140273.
  74. ^ J. Am. Soc. Nephrol., 8 (12): 1971–6, 1997, PMID 9402102 http://jasn.asnjournals.org/cgi/pmidlookup?view=long&pmid=9402102 {{citation}}: Missing or empty |title= (help); Unknown parameter |month= ignored (help)
  75. ^ Moake JL (2004). "von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura". Semin. Hematol. 41 (1): 4–14. doi:10.1053/j.seminhematol.2003.10.003. PMID 14727254.
  76. ^ Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S; et al. (1989). "348 cases of fetal alloimmune thrombocytopenia". Lancet. 1 (8634): 363–6. doi:10.1016/S0140-6736(89)91733-9. PMID 2563515. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  77. ^ Wisnieski JJ, Naff GB (1989). "Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome". Arthritis Rheum. 32 (9): 1119–27. doi:10.1002/anr.1780320910. PMID 2528353. {{cite journal}}: Unknown parameter |month= ignored (help)
  78. ^ "Questions and Answers about Vitiligo". Retrieved 2007-08-06.
  79. ^ "A New Gene Linked to Vitiligo and Susceptibility to Autoimmune Disorders - Journal Watch Dermatology". Archived from the original on 3 September 2007. Retrieved 2007-08-06. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  80. ^ Sánchez-Cano D, Callejas-Rubio JL, Ortego-Centeno N (2008). "Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease". J Clin Rheumatol. 14 (2): 92–3. doi:10.1097/RHU.0b013e31816b4487. PMID 18391678. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  81. ^ Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR, Goh YP, Eagle AR, Dunn SE, Awakuni JU, Nguyen KD, Steinman L, Michie SA, Chawla A. (2009)PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med. 2009 Nov;15(11):1266-72.
  82. ^ Roszer T, Menéndez-Gutiérrez MP, Lefterova MI, Alameda D, Núñez V, Lazar MA, Fischer T, Ricote M.(2011) Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency.J Immunol. 2011 Jan 1;186(1):621-31.
  83. ^ Singh RP, Waldron RT, Hahn BH. (2011) Genes, tolerance and systemic autoimmunity. Autoimmun Rev. 2011 Nov 30.
  84. ^ National Institutes of Health
  85. ^ Noel R. Rose and Ian R. MacKay, “The Autoimmune Diseases” fourth edition
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Autoimmune_disease&oldid=510876613"